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Peptidoglycan LD-Carboxypeptidase Pgp2 Influences
Campylobacter jejuni Helical Cell Shape and Pathogenic
Properties and Provides the Substrate for the
DL-Carboxypeptidase Pgp1*□S
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Background: C. jejuni helical shape is important to pathogenesis.
Results:Deletion of pgp2 results in loss ofC. jejuni helical shape and change in peptidoglycan structure and pathogenic properties.
Conclusion: Pgp2 is a LD-carboxypeptidase cleaving peptidoglycan tetrapeptides to tripeptides.
Significance: Characterization of enzymes involved in C. jejuni peptidoglycan and cell shape maintenance is crucial to the
understanding of fundamental properties of this organism.
Despite the importance ofCampylobacter jejuni as a patho-
gen, little is known about the fundamental aspects of its pep-
tidoglycan (PG) structure and factors modulating its helical
morphology. A PG DL-carboxypeptidase Pgp1 essential for
maintenance of C. jejuni helical shape was recently identified.
Bioinformatic analysis revealed the CJJ81176_0915 gene prod-
uct as co-occurring with Pgp1 in several organisms. Deletion of
cjj81176_0915 (renamed pgp2) resulted in straightmorphology,
representing the second C. jejuni gene affecting cell shape. The
PG structure of apgp2mutant showed an increase in tetrapep-
tide-containing muropeptides and a complete absence of tri-
peptides, consistent with LD-carboxypeptidase activity, which
was confirmed biochemically. PG analysis of a pgp1pgp2
double mutant demonstrated that Pgp2 activity is required to
generate the tripeptide substrate for Pgp1. Loss of pgp2 affected
several pathogenic properties; the deletion strain was defective
for motility in semisolid agar, biofilm formation, and fluores-
cence on calcofluor white. pgp2 PG also caused decreased
stimulation of the human nucleotide-binding oligomerization
domain 1 (Nod1) proinflammatory mediator in comparison
with wild type, as expected from the reduction in muropeptide
tripeptides (the primary Nod1 agonist) in the mutant; however,
these changes didnot alter the ability of thepgp2mutant strain
to survive within human epithelial cells or to elicit secretion
of IL-8 from epithelial cells after infection. The pgp2 mutant
also showed significantly reduced fitness in a chick colonization
model. Collectively, these analyses enhance our understanding
of C. jejuni PGmaturation and help to clarify how PG structure
and cell shape impact pathogenic attributes.
TheGram-negative bacteriumCampylobacter jejuni is a hel-
ical organism exhibiting characteristic corkscrew motility.
Despite fastidious growth requirements, it is a prevalent zoo-
notic organism existing in the intestinal tract of birds and other
animal species (1–3) and is a leading cause of human bacterial
diarrheal disease worldwide (4, 5). The pathogens C. jejuni and
Helicobacter pylori are the most well studied members of the
-Proteobacteria, a relatively poorly characterized class of a
wide variety of bacteria, including numerous extremophiles.
Most members of the -Proteobacteria examined to date dis-
play helical or curved morphology (6).
It has been hypothesized that the helical morphology of
C. jejuni and its polar flagella are responsible for its enhanced
ability in comparison with rod-shaped bacteria to move
through viscous substances, such as the mucus layer of the
gastrointestinal tract (7). Inmost bacteria,morphology ismain-
tained by the peptidoglycan (PG)4 sacculus (8–10). This is also
the case forC. jejunibecause deletion of theC. jejuniPGDL-car-
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boxypeptidase Pgp1 (peptidoglycan peptidase 1) resulted in
loss of helical shape and alterations in a number of stress sur-
vival and host-related attributes (11). Pgp1, which cleaves
monomeric PG tripeptides to dipeptides, was identified in a
calcofluor white (CFW)-based screen for mutants with altered
cell envelope and pathogenic properties (11). CFW is a com-
pound reactingwith1–3 and1–4 carbohydrate linkages and
fluoresces under long wave UV light (12, 13). The C. jejuni car-
bohydrate involved in CFW hypo- versus hyper-reactivity has
not been clarified, although it has been shown not to directly
correlate with the characterized C. jejuni cell surface polysac-
charides: the capsular polysaccharide, lipooligosaccharide,
O-linked flagellar glycoproteins, or N-linked glycoproteins
(14). CFW does bind isolated PG,5 so it is possible that it is the
accessibility of CFW to binding sites on periplasmic PG mole-
cules that determines CFW reactivity differences. Despite hav-
ing changes in PG composition and cell morphology, the rod-
shaped pgp1 mutant showed no apparent differences in
comparison with wild type in other cell surface structures,
growth characteristics, stress survival, and antimicrobial com-
pound sensitivity. The rod-shaped pgp1 was altered in all
aspects of the C. jejuni life cycle: transmission (with reduced
motility in semisolid agar and decreased biofilm formation),
colonization (exhibiting a 3 log-fold reduction in chick coloniza-
tion), and host cell interactions (increased activation of the cyto-
plasmic human nucleotide-binding oligomerization domain 1
(Nod1) receptor bypgp1 PG and increased secretion of the IL-8
chemokine in epithelial cell infections). Surprisingly, the pgp1
mutant was not defective for host cell attachment or invasion in
vitro even in the presence of media of higher viscosity, although
this may not hold true in vivo in intestinal mucus.
We are just beginning to understand fundamental aspects
of PG structure and biosynthesis in this important human
pathogen, along with the unique factors involved in sculpt-
ing its helical morphology. The PG of C. jejuni and all Gram-
negative organisms is composed of glycan strands of alternat-
ing precursors of 1–4-linked N-acetylglucosamine (GlcNAc)
andN-acetylmuramic acid (MurNAc) residues, which are con-
nected by short peptides. The peptides are synthesized as pen-
tapeptides (L-Ala-D-isoglutamic acid-meso-DAP-D-Ala-D-Ala),
which can be cross-linked to dimers or oligomers by DD-trans-
peptidases or trimmed to tetra-, tri-, or dipeptides by DD-, LD-,
and DL-carboxypeptidases, respectively. Themature PG is com-
posed of a mixture of subunits called muropeptides that differ
in the number and length of connected peptides. Themuropep-
tide profile of C. jejuni indicates very low levels of pentapep-
tides and a high abundance of trimmed stem peptide species
(11).
Bioinformatic analyses identified three putative penicil-
lin-binding proteins (PBPs) or PG synthases in C. jejuni:
CJJ81176_0536 with similarity to the bifunctional synthase
PBP1A encoding PG glycosyltransferase and DD-transpeptidase
domains and CJJ81176_0680 and CJJ81176_0550 with homo-
logy to the monofunctional transpeptidases PBP2 (involved in
cell elongation) and PBP3 (involved in cell division), respec-
tively. PG biosynthesis also requires the activity of hydrolases,
allowing for the insertion of newly attached material in cell
elongation and the separation of cells in cell division (8, 9, 15,
16). C. jejuni does have homologs of the lytic transglycosylases
Slt (CJJ81176_0859) and MltD (CJJ81176_0673) as well as the
amidase AmiA (CJJ81176_1285) that probably also play a role
in these processes. PG hydrolases with endo- and carboxypep-
tidase activity are also important in sculpting the PG layer to
determine cell shape (9). C. jejuni does not have predicted
homologs of the low molecular weight PBPs with DD-endo- or
carboxypeptidase activity but does have homologs of the
H. pylori Csd1 endopeptidase and of the Csd3/HdpA endo-/
carboxypeptidase that act on pentapeptide-containing muro-
peptides (17, 18). In H. pylori, deletion of csd1 and csd3 results
in curved rod morphologies with enhanced levels of PG cross-
linking (17).
This study describes the identification and characterization
of the C. jejuni LD-carboxypeptidase Pgp2 (peptidoglycan pep-
tidase 2). Pgp2 trims tetrapeptides to tripeptides and creates the
substrate for Pgp1, with both enzyme activities required for
C. jejunihelicalmorphology. The importance of Pgp2 in a num-
ber of properties related to pathogenesis is also described, most
notably its role in motility, the capacity to form biofilms, the
manner in which C. jejuni is recognized by human cells, and its
ability to colonize a zoonotic avian host.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—Bacterial strains
and plasmids used in this study and their construction are
described in the supplemental Experimental Procedures.
Unless otherwise stated,C. jejuni strains were grown at 38 °C in
Mueller-Hinton (MH; Oxoid) broth or 8.5% (w/v) agar supple-
mented with vancomycin (10 g/ml) and trimethoprim (5
g/ml) (unless otherwise indicated) under microaerobic/cap-
nophilic conditions (6%O2, 12% CO2) in a Sanyo trigas incuba-
tor for plates or using the Oxoid CampyGen system for broth
cultures. Growth media were supplemented with chloram-
phenicol (20 g/ml) or kanamycin (Km; 50 g/ml) where
appropriate. Escherichia coli strains used for plasmid construc-
tion were grown at 37 °C in Luria-Bertani (LB; Sigma) broth or
7.5% agar (w/v) and supplemented with ampicillin (100g/ml),
chloramphenicol (15 g/ml), or Km (25 g/ml), as necessary.
Microscopy—Transmission electron microscopy (TEM)
was carried out on samples fixed in a final concentration of
2.5% (v/v) glutaraldehyde from overnight broth cultures, as
described previously (11). Samples were visualized on aHitachi
H7600 TEM equipped with a side mount AMT Advantage
(1-megapixel) CCD camera (Hamamatsu ORCA) at the UBC
Bioimaging facility (University of BritishColumbia, Vancouver,
Canada).
Phenotypic Characterization; Motility, Biofilm Formation,
and CFW Assays—Phenotypic assays were carried out with
strains that had been grown in shakingMH-trimethoprim-van-
comycin broth for 18 h. Motility, biofilm formation, and CFW
fluorescence were assayed as described previously (11).
Peptidoglycan Isolation andMuropeptideAnalysis—C. jejuni
strains were passaged once from frozen stocks and then pas-
saged to 20–25 MH plates and grown for 20 h to obtain log5 E. Frirdich and E. C. Gaynor, unpublished observations.
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phase bacteria at a final OD of 200–600. Cells were collected
into cold MH broth by scraping, harvested by centrifugation at
8,000 g for 15 min, and then resuspended in 6 ml of ice-cold
H2O. Cells were lysed by dropwise addition to 6 ml of 8% SDS
boiling under reflux. PG was purified from the cell lysate as
described (19). For muropeptide analysis, the isolated PG was
digested with the muramidase cellosyl (kindly provided by
Hoechst, Frankfurt, Germany), and the resulting muropep-
tides were reduced with sodium borohydride and separated
by HPLC, as described (19). Muropeptide structures were
assigned (i) based on comparison with retention times of
known muropeptides from C. jejuni (11) and (ii) by mass spec-
trometry (MS). For MS analysis, muropeptide fractions were
collected, concentrated in a SpeedVac, acidified by 1% trifluo-
roacetic acid, and analyzed by offline electrospray mass spec-
trometry on a Finnigan LTQ-FT mass spectrometer (Thermo-
Electron, Bremen, Germany) at the Newcastle University
Pinnacle facility as described (20).
Expression, Purification, and Enzymatic Activity of Pgp2—
The C. jejuni 81-176 pgp2 gene was cloned for expression in
E. coli without its signal peptide (amino acids 19–325 of the
protein) and stop codon, in frame with the C-terminal His6 tag
of the pET28a vector, generating plasmid pEF70. A detailed
description of the cloning of the expression construct, expres-
sion, and purification protocol is included in the supplemental
Experimental Procedures. For enzyme assays, the purified pro-
tein was dialyzed against 0.05 M Tris-Cl, pH 7.5, containing 0.3
M NaCl and 20% glycerol. Purified pgp2 PG (1 mg/ml) was
incubated with Pgp2-His6 (5 M) in 0.02 M NaH2PO4, pH 4.8,
0.1 M NaCl for 4 h at 37 °C on a Thermomixer at 750 rpm. A
control sample received no enzyme. The samples were incu-
bated with 10g of cellosyl (Hoechst, Frankfurt amMain, Ger-
many) for 18 h, boiled for 10 min, and centrifuged at room
temperature for 15 min at 16,000 g. The muropeptides pres-
ent in the supernatant were reduced with sodium borohydride
and analyzed by HPLC, as described (19).
In Vitro Invasion and Intracellular Survival in Epithelial Cell
Lines—Thehuman epithelial cell linesCaCo2 and INT407were
used forC. jejuni infections.Mediumused for growth of the cell
lines was as directed by the ATCC. Cells were seeded into
24-well tissue culture plates at semiconfluence at5 105 and
1  105 cells/ml for CaCo2 and INT407 cells, respectively.
Infections were carried out as described (11). To test the levels
of invasion in media of higher viscosity to mimic intestinal
mucus, carboxymethylcellulose (CMC) (Sigma) was used.
Infections were carried out as above using the INT407 cell line.
The bacterial inoculum was added in MEM containing 0, 0.6
(141 centipoise (cP)), 1, and 2% CMC. Levels of adhered and
invaded bacteria at the 1 and 3 h time points were determined
by washing and lysing the cells and plating for cfu/ml as
described (11).
Epithelial Cell Responses and Nod Activation Assays—Lucif-
erase assays were performed as described (21). Briefly,
HEK293T cells were transfected overnight with 75 ng of NF-B
luciferase reporter plasmid (Ig-luc, Invitrogen) and either
human Nod1 (2 ng) or Nod2 (0.3 ng). The empty vector
(pcDNA3.1, Invitrogen) was used to balance the transfected
DNA concentration. At the same time, either 0.2 or 2 g of
C. jejuni 81-176, pgp2, or pgp2c PG muropeptides were
added, and the NFB-dependent luciferase activation was then
measured following 18–24 h of co-incubation. To generate
muropeptides, a 2 mg/ml stock of PG of each strain was
digested with mutanolysin at 125 units/100 l overnight at
38 °C. Positive controls were tripeptide L-Ala--D-Glu-meso-
DAP (5 g/ml) and muramyldipeptide (MDP) (10 g/ml) for
Nod1 and Nod2 assays, respectively. Data are representative of
four independent experiments, each performed in triplicate.
Interleukin-8 Quantification—The concentration of IL-8
secreted by INT407human epithelial cells either left uninfected
or infected with C. jejuni wild-type strain 81-176, pgp2, or
pgp2c was assayed using the human IL-8 ELISA kit (Invitro-
gen) as described previously (11).
Chick Colonization—Chick colonization was performed as
described previously (11, 22, 23), with an infective dose of 104
cfu. Briefly, 1-day-old chicks were colonized with 1  104 cfu
via oral gavage. Seven days postcolonization, cecal contents
were removed, diluted in PBS, and plated on Campylobacter-
selective media (MH agar supplemented with vancomycin (40
g/ml), trimethoprim (10 g/ml), cefoparazone (40 g/ml),
and cyclohexamide (100 g/ml)) and allowed to grow at
42 °C under microaerobic conditions until countable colo-
nies appeared (2–3 days). cfu counts were standardized to g
of cecal content. Chicken experiments were carried out under
protocol 10462 approved by the University of Michigan Com-
mittee on Care and Use of Animals.
RESULTS
The pgp2 Gene Was Identified as Interacting with pgp1 by
STRINGAnalysis andDeleted by In-frameDeletion by Selection
on D-Ala—To discover additional C. jejuni proteins involved in
maintaining helical shape, putative protein interaction partners
for Pgp1 were identified bioinformatically by STRING (Search
Tool for the Retrieval of Interacting Genes/Proteins) analysis.
The pgp1 (cjj81176_1344) gene product was found to be asso-
ciated with high confidence to cjj81176_0915 by their co-oc-
currence in numerous organisms. In addition, the two genes
were found to be in the immediate neighborhood of each other
(within 300 bp) on the genome in the -Proteobacteria Nitrat-
iruptor sp. SB155 and Nautilia profundicola, the -Proteobac-
teriumDesulfococcus deovorans, and amember of theAquificae
Persephonella marina. The 0915 gene was named pgp2 (pepti-
doglycan peptidase 2) to describe its function and identification
as the second C. jejuni PG peptidase to be characterized.
Pgp2 is a 325-amino acid protein with a molecular mass of
37.8 kDa that was annotated as a hypothetical protein. It has a
predicted N-terminal signal sequence by SIGNALP that is
cleaved between amino acids 18 and 19. Conserved domain
searches and the threading program PHYRE identified a LD-
transpeptidase-like catalytic domain (YkuD; pfam0734) span-
ning amino acids 67–196. In other organisms, LD-transpepti-
dases have been shown to give rise to an alternative type of PG
cross-linking between the third amino acid (meso-DAP) resi-
dues of the stem peptides and are involved in attaching the
outer membrane lipoprotein Lpp to the PG sacculus. However,
neither meso-DAP-meso-DAP cross-links nor bound lipopro-
teins have been identified inC. jejuni (11), suggesting that Pgp2
Role of pgp2 in C. jejuni PeptidoglycanModification
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might catalyze a different reaction. Unlike pgp1, the pgp2 gene
product is not restricted to helical and vibrioid bacteria and is
conserved in both Gram-negative and Gram-positive organ-
isms. TheH. pylori homolog is described by Sycuro et al. (24). A
putative alanine racemase gene (alr) is encoded directly down-
stream of pgp2 in C. jejuni strain 81-176 (Fig. 1A). Alr catalyzes
the conversion of L- to D-Ala, an essential component of the PG
stem peptide.
To study the role of pgp2 in C. jejuni PG biosynthesis and
morphology, we initially constructed a deletion mutant in
strain 81-176 by replacing a portion of the gene with a non-
polar aphA3 Km resistance cassette. This produced a strain
with completely straight morphology but also modest growth
defects (data not shown). The characteristicC. jejunihelical cell
shape, but not the growth defects, could be complemented by
insertion of the pRRC-pgp2 (pJV4) complementing plasmid
construct (Fig. 1A). This suggested minor polar activity on alr
(predicted to be essential), which was confirmed by full com-
plementation of this initial pgp2mutant with a pRRC derivative
carrying both pgp2 and the downstream alr (not shown). We
thus decided to construct an unmarked, in-frame deletion of
pgp2. An aphA3(Km)-sacB cassette adapted for H. pylori
(pKSFII) (25) was first used to create amarked deletion of pgp2.
We have now confirmed alr deletion to be lethal but also fully
rescued by supplementation of growth medium with D-Ala.6
The aphA3(Km)-sacB-disrupted pgp2mutant strain only grew
on plates containing D-Ala, indicating full polar effects on alr.
Although sucrose counterselection proved unsuccessful, we
reasoned that growth without D-Ala could be used instead as a
counterselection for the creation of an unmarked in-frame
deletion. Transformantswith the aphA3-sacB cassette replaced
by an in-frame deletion of pgp2 were selected by growth on
media without D-Ala to create strainpgp2 (Fig. 1A). The com-
plemented strain created by integration of pRRC carrying pgp2
(pJV4) into the rRNA spacer region of pgp2 is designated
pgp2c (Fig. 1A). A pgp1pgp2 double mutant was also gen-
erated to examine the loss of both genes upon C. jejuni PG
biosynthesis.
Loss of pgp2 Affects Helical Morphology and Has Effects on
Motility, Biofilm Formation, and CFW Reactivity—The pgp2
mutant displayed a straight morphology and loss of the charac-
teristic C. jejuni helical cell shape (Fig. 1B). This was similar to
pgp1; however, pgp2 appeared to have more of an elliptical
shape than pgp1, with a larger cell width at midcell and more
tapered ends than the more rectangle-shaped pgp1. Comple-
mentation restored the wild-type helical shape (Fig. 1B).
The motility of pgp2 in soft agar plates measured by halo
diameter was, on average, 73.7% of wild type (7.8% lower than
the average motility of pgp1) (11) (Fig. 1C). No flagellar struc-
tural defects were observed forpgp2 (Fig. 1B). Complementa-
tion restored motility to 93.0% of wild type (Fig. 1C). Crystal
violet assays were used to assess biofilm formation over 3 days.6 E. Frirdich, J. Vermeulen, and E. C. Gaynor, unpublished observations.
FIGURE1.C. jejuni81-176pgp2gene locus,pgp2mutant straightmorphology, anddefects inmotility, biofilms, andCFWreactivity.A, thepgp2mutant
was constructed by deleting a 439-bp internal fragment of pgp2; the approximate location of this deletion is shown above the gene cluster and is denoted by
the pgp2 strain designation. The region cloned into the integrative vector pRRC (pJV4; CmR) used for complementation is shown below the gene cluster. B,
negatively stained TEM images of thehelicalC. jejuni81-176 strain, the straightpgp1 (describedpreviously (11)) andpgp2mutant strainswith intact flagella,
and complemented strainpgp2cwith restored helicalmorphology. C,pgp2 exhibited a 26.3%decrease inmotility, as assayed bymeasuring halo diameters
in soft agar plates. S.E. (error bars) was calculated from 10measurements.D,pgp2was defective for biofilm formation, which was complemented inpgp2c.
Biofilm formation was assessed by crystal violet staining of standing cultures in borosilicate tubes and quantification of dissolved crystal violet at 570 nm. S.E.
values were calculated from triplicate cultures and are representative of three independent experiments. E, pgp2was hypofluorescent relative to wild-type
81-176 after 24 h but not 48 h of growth on plates containing 0.002% CFW (in contrast, pgp1 remained hypofluorescent after 48 h of growth (11)). pgp2
hypofluorescence was not restored by complementation. *, statistically significant difference using the unpaired Student’s t test, with *, **, and *** indicating
p 0.05, p 0.01, and p 0.0001, respectively.
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Biofilm levels of pgp2 were 1.2-, 1.3-, and 1.2-fold lower in
comparison with wild type at days 1, 2, and 3, respectively (Fig.
1D). Biofilm production was restored in pgp2c (Fig. 1D).
Changes in CFW reactivity typically correlate with biofilm for-
mation differences (11, 14, 26); therefore, CFW reactivity of
pgp2was tested. Thepgp2mutant was hyporeactive relative
to wild type after 24 h of growth on CFW, but after 48 h, it
showedwild-type fluorescence levels (Fig. 1E). This was in con-
trast to pgp1, which maintains hypo-fluorescence for 48 h.
Wild-type CFW reactivity of pgp2 was not restored by
complementation.
The pgp2 mutant exhibited no differences in comparison
with wild type for growth, stress survival, capsule and lipooli-
gosaccharide migration on acrylamide gels, membrane protein
composition, and sensitivity to antimicrobial compounds (sup-
plemental Table S1). The pgp1pgp2 double mutant exhib-
ited an identical morphology, motility, and biofilm phenotype
as pgp2, suggesting pgp2 as epistatic to pgp1, with its CFW
reactivity at 48 h being intermediate between that ofpgp1 and
pgp2 (Fig. 2).
The pgp2 Peptidoglycan Muropeptide Profile Is Distinct
from That of pgp1, Displaying an Increase in Tetrapeptides
and Complete Lack of Tripeptides, with theMuropeptide Profile
of pgp1pgp2 Identical to That of pgp2—The bioinformatic
association of Pgp2 with the PG DL-carboxypeptidase Pgp1, the
presence of putative LD-transpeptidase domains in Pgp2, and
the shape phenotype of pgp2 all indicated that Pgp2 is
involved in PG biosynthesis or modification. PG from the wild-
type 81-176 strain, pgp2 mutant, complemented mutant
(pgp2c), and pgp1pgp2 double mutant were isolated, and
the muropeptide profiles were analyzed by HPLC (Fig. 3, A–D,
Table 1, and supplemental Table S2). The pgp2 mutant dis-
played a complete absence of tripeptides and an increase in
tetrapeptides, both in the monomeric and cross-linked dimeric
and trimeric forms. This suggested that Pgp2 is an LD-carboxy-
peptidase trimming tetrapeptides to tripeptides and that Pgp2
is the only enzyme with such activity present in C. jejuni. The
only other significant change in the muropeptide profile of the
pgp2 mutant was a decrease in the dipeptides. The pgp2c
strain exhibited full complementation to the wild-type profile.
The muropeptide profile of the pgp1pgp2 double mutant
was virtually identical to that of pgp2 (Fig. 3, B and D; see
Table 1 for a comparison of the muropeptide composition of
pgp1pgp2 with that of pgp1 and pgp2).
Pgp2 Is an LD-Carboxypeptidase Cleaving Monomeric and
Cross-linked Disaccharide Tetrapeptides to Tripeptides—To
demonstrate biochemically that Pgp2 is an LD-carboxypepti-
dase trimming tetrapeptides to tripeptides, the Pgp2 protein
was expressed in E. coli without its putative signal peptide and
with a C-terminal His6 tag and purified to 98% purity (Fig.
4A). The purified protein was incubated with PG from the
pgp2 mutant strain and subjected to digestion with cellosyl,
and the resultingmuropeptides were analyzed by HPLC (Fig. 4,
B and C, Table 1, and supplemental Table S2). Incubation with
reaction buffer only caused no change in the muropeptide pro-
file. The addition of Pgp2 resulted in a 94% reduction of mono-
meric tetrapeptides, a 68% reduction in dimeric tetrapeptides,
and a 47% reduction in trimeric tetrapeptides (Table 1). This
analysis showed that Pgp2 is an LD-carboxypeptidase trimming
tetrapeptides to tripeptides with a higher activity on mono-
meric peptides than cross-linked peptides (Table 1 and Fig. 4D).
The Peptidoglycan Changes in pgp2 Result in a Dramatic
Decrease in Human Nod1 Signaling; the pgp2 Mutant Strain
Shows No Change in Intracellular Survival or IL-8 Secretion
from Epithelial Cells but Is Defective for Chick Colonization in
Vivo—Host cell cytoplasmic Nod-like receptors of the innate
immune system recognize PG.HumanNod1 preferentially rec-
ognizes DAP-containing tripeptides unique to Gram-negative
organisms, whereas the minimal molecule recognized by Nod2
is MDP, common to both Gram-negative and Gram-positive
bacteria (27–29). To test whether PG changes resulting from a
pgp2 mutation altered Nod receptor stimulation, we mea-
sured expression of a NF-B lgk luciferase reporter transfected
in human embryonic kidney HEK293T cells along with either
the human Nod1 (Fig. 5A) or Nod2 (Fig. 5B) receptor and PG
from either C. jejuni wild-type 81-176, pgp2 or pgp2c. PG
from pgp2 exhibited a statistically significant reduction in
Nod1 stimulation in comparisonwithwild type at both concen-
trations tested. Specifically, stimulation with 0.2 g of PG
resulted in a 4.4-fold reduction for pgp2 in comparison with
wild type, and stimulation with 2 g of PG resulted in a 16.4-
fold reduction. Nod1 activation bypgp2 PG even at the 0.2-g
concentration was also statistically significant in comparison
with the non-stimulated negative control. PG from the comple-
mented strain restoredNod1 activation to wild-type levels with
the addition of 0.2 g of PG and to nearly wild-type levels with
2 g of PG. There was no statistically significant difference in
FIGURE2.C. jejuni81-176pgp1pgp2doublemutant straightmorphol-
ogy and defects in motility, biofilms, and CFW reactivity. A, negatively
stained TEM images of the straight pgp1pgp2 double mutant strain with
intact flagella showinga similarmorphology topgp2.B,pgp1pgp2exhib-
ited a 27.0% decrease in motility identical to that of pgp2, as assayed by
measuring halo diameters in soft agar plates. S.E. (error bars) was calculated
from 10 measurements. C, pgp1pgp2 was defective for biofilm formation
to the same extent as both pgp1 and pgp2 and is shown after 3 days.
Biofilm formation was assessed by crystal violet staining of standing cultures
in borosilicate tubes and quantification of dissolved crystal violet at 570 nm.
S.E. values were calculated from triplicate cultures and are representative of
three independent experiments. D, on plates containing 0.002% CFW,
pgp1pgp2was hypofluorescent relative towild-type 81-176 after 24 h (like
pgp1 and pgp2) but at 48 h of growth showed intermediate fluorescence
to pgp1 and pgp2. *, statistically significant difference using the unpaired
Student’s t test, with *, **, and *** indicating p  0.05, p  0.01, and p 
0.0001, respectively.
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Nod2 activation levels between the wild-type and pgp2
mutant PG (Fig. 5B).
Gentamicin protection assays were used to assess the ability
of pgp2 to invade and survive intracellularly in vitro in the
human epithelial cell lines INT407 (Fig. 5C) and Caco-2 (data
not shown). Thepgp2mutant strain showed no defect in inva-
sion or intracellular survival in comparison with wild type in
either cell line. Becausepgp2 has a motility defect in soft agar,
we also assessed whether attachment and invasion to epithelial
cells might be altered in a tissue culture medium of higher vis-
cosity by the addition of CMC to the tissue culture media (11,
30). There was no significant difference in the ability of pgp2
in comparison with wild type to invade INT407 cells in the
presence of 0.6, 1, or 2% CMC (data not shown).
Epithelial cells produce IL-8 in response toC. jejuni infection
(31). The effect of loss of pgp2 function on IL-8 secretion was
examined by exposing the INT407 human epithelial cell line to
C. jejuni wild type, pgp2, and pgp2c strains and measuring
the levels of IL-8 in the supernatant after 8 and 24 h by ELISA (Fig.
5D). Data shown are representative of three separate experiments.
There was no significant difference in the levels of IL-8 secreted
from cells exposed to wild-type orpgp2mutant strains.
To assess the role of pgp2 in in vivo colonization, 1-day-old
chicks were orally colonized with a dose of 104C. jejuniwild-
FIGURE 3.HPLC elutionprofile ofC. jejunimuropeptides andproposedmuropeptide structures. Purified PGwas digestedwith cellosyl, and the resulting
muropeptideswere reducedwith sodiumborohydride and separated on a Prontosil 120-3-C18AQ reverse-phase column. HPLCprofiles are shown forC. jejuni
wild-type 81-176 (A), pgp2 (B), the complement pgp2c (C), and the double mutant pgp1pgp2 (D). Peak numbers correspond to the main muropeptide
fractions (11) whose structures are shown in E.G,N-acetylglucosamine;M, reducedN-acetylmuramic acid; D-iGlu, D-isoglutamic acid; Ac, O-acetyl groups at the
C-6 hydroxyl group of MurNAc; Anh, 1,6-anhydro group at MurNAc. *, it is not known on which MurNAc residue the modification occurs.
Role of pgp2 in C. jejuni PeptidoglycanModification
8012 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 12•MARCH 21, 2014
 at N
ew
castle U
niversity on June 12, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
type 81-176 and pgp2. Levels of C. jejuni in the cecal con-
tents were measured 7 days postcolonization. The pgp2
mutant exhibited a statistically significant (p  0.0274) 2.1-
log decrease in average levels of colonization compared with
wild type (Fig. 5E).
DISCUSSION
Elaborate mechanisms are involved in the preservation of
bacterial morphology through growth and cell division, with
morphology being maintained by the structure of the PG
sacculus (8, 9). These mechanisms will differ depending on
the shape of the organism. As predicted from its helical
shape, C. jejunimust encode novel PG synthases or hydrolases
involved in helical shape construction that are not found in
rod-shaped bacteria. The PG DL-carboxypeptidase Pgp1 was
the first unique helical shape determinant identified inC. jejuni
(11). PG synthases and hydrolases are thought to be part of a
multienzyme complex for PG assembly, with several interac-
tions between PG enzymes and between PG enzymes and cyto-
skeletal elements having been reported (8–10, 32). Therefore,
we hypothesized that identifying proteins interactingwith Pgp1
might lead to the discovery of additional members of the
C. jejunimorphogenesis program.
As with a pgp1mutant, deletion of pgp2 resulted in a straight
morphology and significant changes in its PG muropeptide
profile. A direct physical interaction between Pgp1 and Pgp2
could not be shown experimentally through bacterial two-hy-
brid or pull-down assays.6 Enzymatic activity assays demon-
strated that Pgp2 is an LD-carboxypeptidase cleaving mono-
meric and cross-linked PG tetrapeptides to tripeptides, despite
lacking known carboxypeptidase domain(s). Pgp2 is predicted
to have an N-terminal signal peptide and is probably periplas-
mic, acting on periplasmic PG sacculi. Although deletion of
either pgp1 or pgp2 resulted in a loss of helical morphology in
C. jejuni, only pgp1 is conserved in bacteria with mainly curved
or helicalmorphologies (11), whereas pgp2 homologs are found
in a wide variety of Gram-negative and -positive organisms.
However, the precise distribution of Pgp2 is difficult to deter-
mine because similarity searches result in a list of organisms
that encode for a YkuD or LD-transpeptidase catalytic domain,
whereas Pgp2 was instead found to have LD-carboxypeptidase
activity. LD-Carboxypeptidase activity has also been detected in
many Gram-negative and positive species, although only a few
enzymeswith this specificity have been characterized (16). Bac-
terial LD-carboxypeptidases can either be cytoplasmic, cleaving
tetrapeptides in the PG recycling pathway (E. coliLdcA (33, 34),
Pseudomonas aeruginosa Pa5198 (35), andNeisseria meningiti-
dis NMB1620 (36)) or, like Pgp2, have a signal peptide and be
predicted to act in the periplasm on tetrapeptides in cross-
linked PG sacculi (Streptococcus pneumoniae DacB (37) and
Lactococcus lactis DacB (38)).
Consistent with Pgp2 enzymatic activity, the muropeptide
profile of pgp2 shows a complete absence of tripeptide-con-
taining muropeptides and an increase in tetrapeptides. The
decrease in dipeptides is likewise expected because no tripep-
TABLE 1
Summary of the muropeptide composition of C. jejuni wild-type 81-176, pgp2, pgp2 complement (pgp2c), pgp1pgp2 double mutant,
and pgp1 and the resultant pgp2 PG profiles of Pgp2 activity assays consisting of pgp2 PG incubated with and without Pgp2 enzyme
preparations
Values represent the percentage area of each muropeptide from supplemental Table S2 calculated to give a total of 100%. Values indicated with an asterisk represent a
greater than or equal to 20% difference in comparison with C. jejuniwild-type 81-176 orpgp2 PG to which no enzyme was added, and boldface, asterisked values indicate
a greater than or equal to 30% change.
Muropeptide species
Percentage of peak area
In C. jejuni strains Following incubation with pgp2 PG
81-176 pgp2 pgp2c pgp1pgp2 pgp1a pgp2 PG buffer pgp2 PG Pgp2
% % % % % % %
Monomers
Di 15.3 9.1* 14.8 10.2* 5.9 9.8 11.0
Tri 8.9 0.0* 7.4 0.0* 34.4 0.0 39.0*
Tetra 17.7 31.7* 19.6 30.7* 3.1 30.9 1.4*
Anhydro 0.0 6.2*
Total 41.6 40.8 41.8 40.9 43.4 40.7 51.4*
Dimers
TetraTri 16.0 0.0* 14.2 0.0* 37.0 0.0 24.5*
TetraTetra 31.1 46.8* 33.2 46.9* 14.7 49.1 16.1*
Tetra PentaGly5 0.7 0.8 0.7 1.0* 0.7 1.0 1.0
Anhydro 12.5 12.1 12.7 11.8 11.7 12.3 7.0*
Total 47.9 47.6 48.0 47.9 52.5 50.1 41.5
Trimers
TetraTetraTri 1.0 0.0* 0.8 0.0* 1.9 0.0 2.3*
TetraTetraTetra 9.5 11.6 9.4 11.2 2.3 9.2 4.8*
Total 10.5 11.6 10.2 11.2 4.2 9.2 7.1
Dipeptides (Total) 15.3 9.1* 14.8 10.2* 5.9 9.8 11.0
Tripeptides (Total) 17.3 0.0* 14.7 0.0* 53.6 0.0 52.0*
Tetrapeptides (Total) 67.0 90.5* 70.2 89.3* 40.2 89.7 36.5*
Pentapeptides (Total) 0.4 0.4 0.4 0.5 0.4 0.5 0.5
Anhydro chain ends (Total) 7.9 8.0 8.0 7.8 6.4 8.1 10.5*
Average chain length 12.7 12.5 12.5 12.8 15.7 12.4 9.5*
Degree of cross-linkage 31.0 31.6 30.8 31.5 29.0 31.2 25.5
Percentage of peptides in cross-links 58.4 59.2 58.2 59.2 56.6 59.3 48.6
a Values for pgp1 are as published previously (11). For characterization of the differences between wild type and pgp1, see Frirdich et al. (11). Differences between the wild
type and pgp1 are not highlighted with boldface and asterisked values.
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tides are present to serve as the substrate for the DL-carboxy-
peptidase Pgp1, which forms dipeptides from monomeric
tripeptides. The muropeptide profile of the double mutant
pgp1pgp2 was identical to that of the single pgp2 mutant,
further substantiating that Pgp2-mediated tripeptide forma-
tion is required for Pgp1 activity. Because deletion of pgp2 elim-
inates the Pgp1 substrate, and pgp1 is restricted to bacteria with
curved or helical morphologies whereas pgp2 is not, it is possi-
ble that Pgp1 alone is necessary forC. jejuni helical shapemain-
tenance. There is still a residual amount of dipeptide (9–10%)
present in the PG of both pgp2 and pgp1pgp2, suggesting
that Pgp1 is not the only enzyme capable of forming dipeptide
disaccharides and that C. jejuni probably encodes a hydrolase
capable of cleaving pentapeptides or tetrapeptides to dipeptides
that remains to be identified.
The shape of a bacterium has biological relevance (39, 40),
and thus there is probably selective pressure for a bacterium
like C. jejuni to retain its helical shape. It is therefore not sur-
prising that C. jejuni pathogenic and survival attributes were
altered when either pgp1 or pgp2 was deleted and helical mor-
phology was lost. One consequence of pgp2 deletion was a
reduced motility in soft agar. The motility defect of pgp2 was
reproducibly greater than that of pgp1, possibly as a result of
differences in the rod-shaped morphologies of the mutants
affecting their swimming ability. Alternatively, despite what
appears by TEM to be fully formed flagella on the cell surface of
pgp1 and pgp2, loss of PG hydrolases such as Pgp1 and, to a
greater extent, Pgp2 may affect the proper assembly and/or
function of the flagellar apparatus. Flagellar assembly may be
less efficient than in the wild type because localized PG remod-
eling by PGhydrolases has been shown in other organisms to be
required to create gaps in the PG layer permitting insertion of
the multiprotein flagellar complex through the cell envelope
(16, 41). An alternative explanation may be that flagellar func-
tion is compromised in the hydrolase mutants. In Gram-nega-
tive bacteria, PG interacts with theMotB protein of the flagellar
MotA-MotB stator complex responsible for generating torque
for flagellar rotation (42–45). InH. pylori, a mutant lacking the
lytic transglycosylase MltD that cleaves the PG glycan back-
bone is non-motile, displaying a paralyzed phenotype with nor-
mally assembled flagella that are impaired in flagellar rotation
and torque generation (46). Changes in PG structure resulting
from Pgp1 and Pgp2 activities could alter interactions between
MotB and PG residues, affecting the efficiency of flagellar
rotation.
With C. jejuni motility being important for biofilm forma-
tion (47–49), the decreased motility of pgp2may account for
the modest biofilm defect. However, alterations in PG remod-
eling could also affect another C. jejuni factor required for bio-
film development. Mutants in PG hydrolases or PG biosyn-
thetic enzymes have also been shown to exhibit biofilm defects
in several other organisms, such as E. coli (50, 51),Burkholderia
cepacia (52), Streptococcus gordonii (53), and L. lactis (54);
however, it also remains to be shown in these organisms what
FIGURE 4. Pgp2 has LD-carboxypeptidase activity on pgp2 PG, cleaving monomeric and cross-linked disaccharide tetrapeptides to tripeptides. A,
SDS-PAGE analysis of affinity-purified Pgp2with a predictedmolecularmass of 37.0 kDa, indicated by an arrow. Shown are HPLC chromatograms ofpgp2 PG
(B) andpgp2PG incubatedwithpurifiedPgp2, followedby cellosyl digestion and reductionwith sodiumborohydride (C). Peaks corresponding tomonomeric
disaccharide tripeptide (Tri) and disaccharide tetrapeptide (Tetra) and dimeric bis-disaccharide tetratripeptide (TetraTri) and bis-saccharide tetratetrapeptide
(TetraTetra) are indicated. D, schematic diagram of the Pgp1 (determined in Ref. 11); Pgp2 carboxypeptidase cleavage sites are indicated with an arrow. Note
that Pgp2 hydrolyzes tetrapeptides, and Pgp1 hydrolyzes tripeptides. G, N-acetylglucosamine;M, N-acetylmuramic acid; D-iGlu, D-isoglutamic acid.
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specific cell surface organelle or adhesin is affected. The pgp2
biofilm defect along with the hyporeactivity this mutant dis-
played on CFW further supports the link between CFW reac-
tivity and key C. jejuni pathogenic properties, as described pre-
viously (11, 14, 26). CFW hyporeactivity of pgp2 was only
apparent for the first 24 h following incubation, unlike that of
pgp1, which remained hyporeactive after 48 h. The pgp1
mutant was identified in a screen for hypofluorescent mutants
after growth for 48 h on CFW, so it is not surprising that a
mutant in pgp2 was not isolated in that screen. The differences
in CFW reactivity between pgp1 and pgp2 indicate that the
mutants probably display different cell envelope properties
during bacterial growth. One possible explanation may be that
the mutants allow differential access to CFW binding sites on
the PG during the aging process.
The changes in morphology, phenotypic properties, and PG
muropeptide profile of pgp2 differ from wild type but also
from pgp1 (11). These changes may also have unique effects
on host interactions. Host epithelial cell innate immune
responses toC. jejuni can be triggered by the activation of cyto-
plasmicNod receptors recognizing bacterial muropeptides (55,
56). DAP-containing muropeptides serve as ligands for Nod1
receptors (57–59), with humanNod1 primarily recognizing tri-
peptides (60) and the motif recognized by human Nod2 being
FIGURE 5.Theeffect ofpgp2deletiononhost-relatedphenotypes.A and B, PG isolated from thepgp2mutant shows reducedhumanNod1 activation and
no change in human Nod2 stimulation. To assay the change in the ability of C. jejuni pgp2 PG to activate Nod proteins, human embryonic kidney cells
(HEK293T) were co-transfected with either 0.2 or 2g of C. jejuni 81-176,pgp2, orpgp2c PG, vectors for a nuclear factor-B (NF-B) luciferase reporter, and
eitherNod1 (A) orNod2 (B). Nodactivationwasdeterminedbymeasuring the activity of aNF-B luciferase reporter in comparisonwith thenon-stimulated (NS)
negative control. Positive controls used were tripeptide L-Ala--D-Glu-meso-DAP (TriDAP) and MDP. Data represent the mean  S.E. of four independent
experiments. C, invasion and intracellular survival ability of the pgp2 strain in the INT407 epithelial cell line was assessed by a gentamicin (Gm) protection
assay and showednochange in comparisonwithwild type.Gentamicinwas added3hpostinfectionwith theC. jejuniwild-type81-176andpgp2 strains. After
2 h, the gentamicin was washed off, and the cells were incubated with fresh MEM containing 3% FBS and a low dose of gentamicin. cfu were determined for
each well by lysing the cells with water and plating the dilutions onto MH-trimethoprim-vancomycin plates. Data represent the mean  S.E. of three
independent experiments. D, pgp2 deletion has no effect on IL-8 secretion in the INT407 epithelial cell line. ELISA was used to quantify IL-8 levels secreted by
uninfected INT407 epithelial cell lines and cells infected for 8 and 24 h with C. jejuniwild-type 81-176,pgp2, andpgp2c strains. Data represent themean
S.E. (error bars) of three independent experiments. E, the pgp2 mutant strain is defective for chick colonization. Each point represents the log cfu/g cecal
contentsof an individual chick7dayspostcolonizationwith104 cfuof the indicatedC. jejuni strains. Thegeometricmean isdenotedbyablackbar. *, statistically
significant difference using the unpaired Student’s t test, with *, **, and *** indicating p 0.05, p 0.01, and p 0.0001, respectively.
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MDP (61, 62). The complete absence of tripeptide-containing
muropeptides inpgp2PG is reflected in the reduction ofNod1
activation in comparison with wild type. Despite a decrease in
dipeptides, there was no change in Nod2 activation levels. This
was also observed with the decreased levels of dipeptides in
pgp1 PG (11). It is possible that Nod2 is not very sensitive to
changes in levels of C. jejuni dipeptides. Our previous (11) and
current work and that of Al-Sayeqh et al. (55) show that
C. jejuni PG can activate Nod2, although that of Zilbauer et al.
(56) did not. This may be the result of differences in the cell
lines used or in reporter sensitivity.
A reduction in Nod1 activation by pgp2muropeptides had
no effect on the ability of pgp2 to survive intracellularly in in
vitro epithelial cell infections or on the secretion of the proin-
flammatory mediator IL-8. IL-8 is released by intestinal epithe-
lial cells in response toC. jejuni (63, 64) and can be triggered by
Nod1 activation (56). pgp1 muropeptides hyperactivated
Nod1, and IL-8 secretion did increase as a result of intestinal
epithelial cell infection with the pgp1 strain, yet pgp2muro-
peptides showed a drastic decrease in Nod1 activation with no
effect on IL-8 levels secreted in response to the pgp2 strain in
comparison with wild type. This could suggest that either only
a certain base line of Nod1 activation is required for IL-8 secre-
tion by epithelial cells, with further increases in IL-8 release
resulting only when Nod1 activation rises beyond a certain
threshold, or that other pathways in addition to Nod1 activa-
tion can result in IL-8 secretion (55, 64, 65). Therefore, the role
of other bacterial factors, in addition to PG, in triggering IL-8
cannot be ruled out.
As with pgp1 and despite a more pronounced motility
defect in soft agar, pgp2 was not impaired in host cell attach-
ment, invasion, or intracellular survival in vitro, even in higher
viscosity media. The helical morphology and polar flagella of
C. jejuni are thought to be responsible for the high velocity
dartingmotility observed by this organism in viscousmedia (7).
Therefore, a loss of helical morphology and defect in soft agar
motility would have been predicted to affect the ability of the
organism to make contact with epithelial cells in higher viscos-
ity media, yet pgp2 exhibited wild-type levels of epithelial cell
attachment and invasion in vitro.
C. jejuni motility is also a key factor in in vivo colonization
(22, 66–70), although our previous work showed that a
decrease in motility alone was not sufficient to affect coloniza-
tion in a carB mutant (carB encodes carbamoylphosphate
synthase), which, other than displaying a slight motility defect,
exhibited helical shape and wild-type phenotypes for all other
attributes tested (11). TheC. jejuni helical shape and associated
corkscrew motility have been hypothesized to be important in
colonization, enablingC. jejuni to burrow through themucosal
layer. This is supported by the chick colonization defect of both
pgp1 and pgp2 mutant strains that have lost their helical
shape in addition to displaying reduced motility (11). C. jejuni
colonization could be affected not only by a change in shape or
in motility, but by the change in PG structure underlying the
alteration in morphology. Despite both displaying straight
morphology and having a similar effect on chick colonization,
the pgp1 and pgp2 mutants have significantly different PG
compositions, although both strains have a decrease in the level
of dipeptides in comparison with wild type. Dipeptides are rec-
ognized by the Nod2 immune receptor, and although the
chicken genome does not encode for a Nod2 receptor, it does
possess an ortholog of the NLRP3/NALP3 Nod-like receptor
that is similar to Nod2 and also binds MDP (71, 72). A more in
depth understanding of chicken innate immunity and the role
of dipeptides in signaling is required. Nonetheless, because Nod2
has been proposed to play a regulatory role in innate immune
responses in mammalian systems (73), it is possible that
reduced receptor signaling by decreased levels of dipeptides
affects the chicken immune response to C. jejuni pgp1 and
pgp2, thereby altering colonization levels. It also cannot be
ruled out thatpgp1 andpgp2mutations or changes to the PG
structures in those mutants are affecting other, so far unidenti-
fied, bacterial cell envelope factors important in bacterial sur-
vival in the chick cecum or in host cell interactions mediating
chicken immune responses.
Our ongoing characterization of PG synthesis or modifica-
tion enzymes will provide additional insight into how helical
shape is determined inC. jejuni and is necessary before amodel
can be proposed.We now know that at least Pgp1 and Pgp2 are
required for helical twist in C. jejuni, although the addition of
these enzymes to E. coli was not sufficient to transform E. coli
from a rod to a helix shape,5 indicating that the presence of
other proteins is required either for proper localization of Pgp1
and Pgp2 or for remodeling of the PG to act as a proper sub-
strate. Other enzymes will probably affect the amount of helical
curvature, with several candidates being theC. jejuni homologs
of theH. pyloriCsd1, CcmA, and Csd3/HdpA proteins (17, 18).
The characterization of the pgp2 mutant as the second
defined rod-shaped mutant after pgp1 serves to confirm the
effects of the loss of helical morphology on the biology of
C. jejuni described for pgp1. However, it is difficult to attrib-
ute these defects solely to the loss of helical shape because
changes in PG and the deletion of PG hydrolases can also have
an effect on biological properties such as motility and biofilm
formation. The PG muropeptides of pgp2 are distinct from
those of pgp1 and differentially stimulate the epithelial cell
Nod1 receptor. Because Nod activation is an important aspect
of epithelial cell sensing toC. jejuni (56), continued studieswith
mutants with different muropeptide profiles will also lead to
a better understanding of the effects of muropeptide struc-
ture on Nod sensing and their downstream effects on
C. jejuni pathogenesis.
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